Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 1
1988 1
1991 1
1994 1
1995 1
1996 1
1997 2
1998 1
1999 2
2000 1
2001 2
2005 1
2006 1
2007 1
2008 3
2010 3
2011 1
2012 3
2014 2
2015 3
2017 4
2018 4
2019 9
2020 1
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean o sullivan a[au] (395 results)?
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype.
Sallman DA, McLemore AF, Aldrich AL, Komrokji RS, McGraw KL, Dhawan A, Geyer S, Hou HA, Eksioglu EA, Sullivan A, Warren S, MacBeth KJ, Meggendorfer M, Haferlach T, Boettcher S, Ebert BL, Al Ali NH, Lancet JE, Cleveland JL, Padron E, List AF. Sallman DA, et al. Among authors: sullivan a. Blood. 2020 Dec 10;136(24):2812-2823. doi: 10.1182/blood.2020006158. Blood. 2020. PMID: 32730593 Free PMC article.
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
Devereux G, Cotton S, Fielding S, McMeekin N, Barnes PJ, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Gompertz S, Haughney J, Innes K, Kaniewska J, Lee A, Morice A, Norrie J, Sullivan A, Wilson A, Price D. Devereux G, et al. Among authors: sullivan a. JAMA. 2018 Oct 16;320(15):1548-1559. doi: 10.1001/jama.2018.14432. JAMA. 2018. PMID: 30326124 Free PMC article. Clinical Trial.
Preclinical investigations have demonstrated that low plasma concentrations (1-5 mg/L) of theophylline enhance antiinflammatory effects of corticosteroids in COPD. ...INTERVENTIONS: Participants were randomized to receive low-dose theophylline (200 mg once or twice per day …
Preclinical investigations have demonstrated that low plasma concentrations (1-5 mg/L) of theophylline enhance antiinflammatory effec …
Progress in Parkinson's disease-where do we stand?
Toulouse A, Sullivan AM. Toulouse A, et al. Among authors: sullivan am. Prog Neurobiol. 2008 Aug;85(4):376-92. doi: 10.1016/j.pneurobio.2008.05.003. Epub 2008 Jun 5. Prog Neurobiol. 2008. PMID: 18582530 Review.
It is one of the most common neurodegenerative disorders, affecting the nigrostriatal pathways involved in the control of movement. Since the introduction of L-DOPA as a therapy in the mid-1960s, clinical management of the symptoms has progressed, but, at present, it remai …
It is one of the most common neurodegenerative disorders, affecting the nigrostriatal pathways involved in the control of movement. Since th …
Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor.
Christiansen MP, Garg SK, Brazg R, Bode BW, Bailey TS, Slover RH, Sullivan A, Huang S, Shin J, Lee SW, Kaufman FR. Christiansen MP, et al. Among authors: sullivan a. Diabetes Technol Ther. 2017 Aug;19(8):446-456. doi: 10.1089/dia.2017.0087. Epub 2017 Jul 12. Diabetes Technol Ther. 2017. PMID: 28700272 Free PMC article.
Exploring the interaction of knee and ankle component use on mobility test performance in people with unilateral transfemoral amputation.
Barnett CT, Hughes LD, Sullivan AE, Strutzenberger G, Levick JL, Bisele M, De Asha AR. Barnett CT, et al. Among authors: sullivan ae. Prosthet Orthot Int. 2021 Dec 1;45(6):470-476. doi: 10.1097/PXR.0000000000000042. Prosthet Orthot Int. 2021. PMID: 34538818
METHODS: Nine adults with unilateral transfemoral amputation completed the two-minute walk test, the timed up-and-go test, the L-test, and a custom locomotion course in four randomized prosthetic conditions. ...This effect was statistically significant for the two-minute w …
METHODS: Nine adults with unilateral transfemoral amputation completed the two-minute walk test, the timed up-and-go test, the L-test …
The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells.
Alshangiti AM, Togher KL, Hegarty SV, Sullivan AM, O'Keeffe GW. Alshangiti AM, et al. Among authors: sullivan am. Neuronal Signal. 2019 Mar;3(1):NS20180201. doi: 10.1042/NS20180201. Epub 2019 Jan 30. Neuronal Signal. 2019. PMID: 32269833 Free PMC article.
The cytotoxic effect of ISLQ was blocked by small molecule inhibitors of oxidative stress-induced cell death, and by the antioxidant N-acetyl-l-cysteine (NAC). Combined treatment of either SK-N-B-E(2) or IMR-32 cells with ISLQ and the anticancer agent cisplatin resulted in …
The cytotoxic effect of ISLQ was blocked by small molecule inhibitors of oxidative stress-induced cell death, and by the antioxidant N-acety …
Structures of prostaglandin F synthase from the protozoa Leishmania major and Trypanosoma cruzi with NADP.
Moen SO, Fairman JW, Barnes SR, Sullivan A, Nakazawa-Hewitt S, Van Voorhis WC, Staker BL, Lorimer DD, Myler PJ, Edwards TE. Moen SO, et al. Among authors: sullivan a. Acta Crystallogr F Struct Biol Commun. 2015 May;71(Pt 5):609-14. doi: 10.1107/S2053230X15006883. Epub 2015 Apr 21. Acta Crystallogr F Struct Biol Commun. 2015. PMID: 25945716 Free PMC article.
The crystal structures of prostaglandin F synthase (PGF) from both Leishmania major and Trypanosoma cruzi with and without their cofactor NADP have been determined to resolutions of 2.6 A for T. cruzi PGF, 1.25 A for T. cruzi PGF with NADP, 1.6 A for L. major PGF and 1.8 A …
The crystal structures of prostaglandin F synthase (PGF) from both Leishmania major and Trypanosoma cruzi with and without their cofactor NA …
55 results